MOdifiable facTors to Improve VentilAtion ThErapy in ICU
Launched by NAT INTENSIVE CARE SURVEILLANCE - MORU · Feb 24, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The MOdifiable facTors to Improve VentilAtion ThErapy in ICU trial is researching ways to improve the care of patients who need invasive mechanical ventilation (a type of breathing support) in intensive care units (ICUs) in Uganda. The goal is to find specific factors that could help reduce the number of patients who do not survive their ICU stay. This study will look at both patient-related factors (like age and health conditions) and factors related to how care is provided in the ICU (such as staff levels and sedation practices). By understanding these factors, the researchers hope to improve outcomes for critically ill patients in low and middle-income countries.
To participate in this study, patients who are 15 years or older and require invasive mechanical ventilation during their hospital stay may be eligible. Those who have been successfully taken off the ventilator within two days, are receiving end-of-life care, or are transferred from non-participating ICUs will not be included. Participants will be monitored for their ICU stay, how long they need ventilation, and any complications that arise. Importantly, patient privacy will be protected throughout the study, and the findings will be shared to help improve care in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Invasive mechanical ventilatory support initiated anywhere within the study hospital i.e., emergency room, normal ward or in the operating room, or in the ICU at any time during admission.
- Exclusion Criteria:
- • Successful extubations within two calendar days of intubation
- • Admissions for end-of-life care and/or ICU palliative support
- • Patients transferred from ICUs not participating in the study 24 hours after initiation of MV.
- • Refusal or Withdrawal of consent
About Nat Intensive Care Surveillance Moru
NAT Intensive Care Surveillance, affiliated with the Mahidol-Oxford Tropical Medicine Research Unit (MORU), is dedicated to advancing critical care medicine through innovative research and data-driven insights. By leveraging a robust framework of intensive care unit (ICU) surveillance, NAT aims to enhance patient outcomes and inform best practices in critical care environments. The organization fosters collaboration among healthcare professionals and researchers, focusing on the implementation of evidence-based strategies to address the complexities of patient care in ICU settings, ultimately contributing to improved healthcare systems and practices globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported